Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
Humans are less sensitive to the therapeutic effects of botulinum neurotoxin B (BoNT/B) than the animal models it is tested on due to differences between the human and the mouse receptors. Here, the authors engineer BoNT/B to improve its affinity to human receptors and enhance its therapeutic effica...
Enregistré dans:
| Auteurs principaux: | Liang Tao, Lisheng Peng, Ronnie P.-A. Berntsson, Sai Man Liu, SunHyun Park, Feifan Yu, Christopher Boone, Shilpa Palan, Matthew Beard, Pierre-Etienne Chabrier, Pål Stenmark, Johannes Krupp, Min Dong |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c4a98be4d71a49939f118b13ff4c9b03 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC
par: Sicai Zhang, et autres
Publié: (2017) -
Identification and characterization of a novel botulinum neurotoxin
par: Sicai Zhang, et autres
Publié: (2017) -
On Botulinum Neurotoxin Variability
par: Cesare Montecucco, et autres
Publié: (2015) -
Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins.
par: Hatim Thaker, et autres
Publié: (2021) -
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
par: Cindy Périer, et autres
Publié: (2021)